Ana Jimenez-Marcos
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Dasatinib reversibly disrupts T cell motility and activation in lymph nodes.
Journal: Science advances
Published: August 05, 2026
Modulation of TLR7, TYK2 and OAS1 expression during SARS-CoV-2 infection.
Journal: Frontiers in immunology
Published: September 26, 2025
Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables.
Journal: Scientific reports
Published: December 14, 2023
Evaluation of the novel therapeutic anti-CCR7 antibody CAP-100 as an add-on therapy in chronic lymphocytic leukemia patients receiving venetoclax.
Journal: Hematological oncology
Published: April 18, 2023
NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins.
Journal: Nature communications
Published: April 14, 2023
Dasatinib-induced spleen contraction leads to transient lymphocytosis.
Journal: Blood advances
Published: November 02, 2022
Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation.
Journal: iScience
Published: March 29, 2022
Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial.
Journal: Scientific reports
Published: December 03, 2021
Last Updated: 09/26/2026